According to a research report "Exoskeleton Market with COVID-19 Impact by Type (Powered, Passive), Component (Hardware, Software), Mobility, Body Part (Lower Extremities, Upper Extremities, Full Body), Vertical (Healthcare, Defense, Industrial) and Region - Global Forecast to 2026" published by MarketsandMarkets,the exoskeleton market is valued at USD 499 million in 2021 and is projected to reach USD 3,340 million by 2026; it is expected to grow at a CAGR of 46.2% from 2021 to 2026.
Browse 125 market data Tables and 49 Figures spread through 201 Pages and in-depth TOC on "Exoskeleton Market with COVID-19 Impact by Type (Powered, Passive), Component (Hardware, Software), Mobility, Body Part (Lower Extremities, Upper Extremities, Full Body), Vertical (Healthcare, Defense, Industrial) and Region - Global Forecast to 2026"
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40697797
Factors such as the increasing adoption of human augmentation in industrial and military sectors, the introduction of soft actuators, and growing insurance coverage for exoskeletons are likely to provide opportunities for market growth.
The exoskeleton market includes major Tier I and II players like Ottobock (Germany), DIH Medical (China), CYBERDYNE (Japan), Ekso Bionics. (US), Lockheed Martin Corporation (US) and others. These players have a strong market presence for exoskeleton across various countries in North America, Europe, APAC, and RoW.
Increasing adoption of human augmentation equipment in industrial and military sectors
Many companies are enhancing their facilities using exoskeletons. Also, with the evolution across industrial and military sectors, the need for automation is also increasing; hence, manufacturers are focusing on developing prototypes that can adapt to the real-time need for exoskeletons. Thus, the intensifying need for human augmentation in industrial and military sectors creates opportunities for the growth of the exoskeleton market.
Powered exoskeleton segment is expected to grow at the highest rate during the forecast period
Powered exoskeletons accounted for the larger share of the overall exoskeleton market in 2020. The high cost of powered exoskeletons leads to a higher market share of the technology compared to passive exoskeletons. At present, powered exoskeletons are mainly used in the healthcare vertical to assist people with disabilities, but with the introduction of cost-efficient systems and because of their additional benefits over the passive ones, powered exoskeletons will find their applications in several new verticals, ultimately resulting in the high growth of the segment during the forecast period.
Healthcare vertical to hold the largest market size of exoskeleton market during the forecast period
Exoskeletons are being widely deployed at rehabilitation centers for therapies to assist people with disabilities; owing to this, the healthcare segment accounted for the largest share of the exoskeleton market in 2020. Over the last few years, there have been major developments in this field, giving hope to people with spinal cord injuries, neurological disorders, and strokes. The use of these devices during rehabilitation is growing, and their benefits are becoming more widely recognized. Moreover, the increasing usage approvals for exoskeletons in the medical industry have encouraged companies to invest more in the research and development of exoskeletons.
Exoskeleton market in North America to hold the highest market share during the forecast period
North America is a major regional market for exoskeletons. The growth of the market can be attributed to the presence of major players, their subsidiaries, distributors, and resellers in this region. Growing demand from the healthcare sector for rehabilitation, advancements in robotic technologies, and huge investments made for the development of exoskeleton technology is boosting the demand for exoskeletons in North America.
Ottobock (Germany), DIH Medical (China), CYBERDYNE (Japan), Ekso Bionics. (US), Lockheed Martin Corporation (US), ATOUN. (Japan), BIONIK (Canada), B-Temia (Canada), MediTouch (Israel), ReWalk Robotics (US), Daiya Industry (Japan), Europe Technologies (France), Exhauss (France), Focal Meditech BV (Netherlands), Fourier Intelligence (China), Gogoa Mobility (Spain), Honda Motor Co (Japan), Hyundai Motors (South Korea), Mitsubishi Heavy Industries (Japan), Myomo (US), Parker Hannifin (US), P&S Mechanics (South Korea), Rex Bionics (UK), suitX (US) and Wandercraft (France) are some of the key players in the exoskeleton market.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441